HRT Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
3.9%
Last Quarter
-$0.05
Past Year
-$0.11
Growth Past 5yrs
N/A
Next Quarter
$0.39
Estimate Next Year
$20.85
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
(
0% Upside
)Mean Price Target
N/A
(
0% Upside
)Lowest Price Target
N/A
(
0% Upside
)Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
HRT Earnings Per Share (EPS) History
According to financial reports, HRT (NYSE: HRT) reported an actual EPS of $-0.05259 for the quarter ending on Jun 21, 2024, compared to an estimated $0.21, resulting in a -125.04% surprise. In the prior quarter (May 24, 2024), HRT recorded an actual EPS of $-0.05259 with a -125.04% surprise. See HRT's full earnings history.
Earnings History
EPS Surprise Factor Analysis
HRT has experienced notable EPS surprises, with the latest quarter ending Jun 21, 2024 showing a -125.04% miss. Previously, the quarter ending May 24, 2024 recorded a -125.04% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is HRT stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given HRT stock an average recommendation of
N/A. 0 analysts have given their ratings
to HRT out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for HRT highest price target?
Analysts suggest HRT's stock price would rise to a high of -.
What is the lowest price target analysts expect for HRT over the next year?
Within the next 12 months, analysts predict the HRT stock price could move to -.
What is the average target price for HRT?
HRT stock has an average analyst estimate of -.
At its current price, how far is HRT from its average target price?
HRT shares are currently trading 0% below this price target.
What were HRT’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at -$0.05 versus consensus estimates of $0.21, and below the comparable year-ago quarter’s EPS of $0.23.
What are the current estimates for quarterly and annual earnings per share?
HRT's forecasts by analysts estimating quarterly EPS at $0.39 and $20.85 for the whole year.
What has HRT's growth been in the past five years and what is expected in the next five years?
The analysts have projected 3.9% EPS growth for HRT in the next five years, compared to growth rates of N/A in the past five years.